Home2025-07-01T15:19:12+00:00
Loading...

Latest News

New Dataset: Window of opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastoma

July 23, 2025|Categories: CCKP, Data Features|Tags: , , |

This dataset investigates the effectiveness of p53 reactivation in treating glioblastoma. They achieve this by treating multiple patients with differing levels of MDM2 inhibitor [...]

Go to Top